BCAX as of Oct 31 · 15:33 ET

BCAXNasdaqPharmaceutical Preparations

Bicara Therapeutics Inc. · Brief

Next report

9 days

Nov 9 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±19.7%implied · report alone

7.3310.93

straddle ±34.9%

spot 9.13exp Nov 20ATM strike 10ATM straddle 3.75IV 204%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

0 of 7≥ implied

avg implied: ±22.4%
avg realized: ±4.6%

Nov 12 '24±17.0%▼−7.30%×0.43

Mar 27 '25±29.3%▲+2.29%×0.08

May 13 '25±27.4%▼−8.10%×0.30

Aug 12 '25±21.2%▲+4.80%×0.23

Q3 FY25±29.2%▼−4.85%×0.17

Q1 FY26±13.5%▲+3.65%×0.27

May 11 '26±19.1%▲+1.51%×0.08

Q2 FY26—▼−14.32%—

quarterimplied−30%0+30%realized×

Q2 FY26—▼−14.32%—

May '26±19.1%▲+1.51%×0.08

Q1 FY26±13.5%▲+3.65%×0.27

Q3 FY25±29.2%▼−4.85%×0.17

Aug '25±21.2%▲+4.80%×0.23

May '25±27.4%▼−8.10%×0.30

2 older reports

Mar '25±29.3%▲+2.29%×0.08

Nov '24±17.0%▼−7.30%×0.43

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

175managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+3.54%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

0.30%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

9 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

BCAX report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 26impliedImplied move: ±25.9% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.